https://orcid.org/0000-0003-2257-8500
Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Adriana Petrazzuolo, M. Chiara Maiuri, Laurence Zitvogel, Guido Kroemer & Oliver Kepp. (2022) Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy. OncoImmunology 11:1.
Read now
Read now
Takahiro Yamazaki, Erik Wennerberg, Michal Hensler, Aitziber Buqué, Jeffrey Kraynak, Jitka Fucikova, Xi Kathy Zhou, Baldur Sveinbjørnsson, Øystein Rekdal, Sandra Demaria & Lorenzo Galluzzi. (2021) LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. OncoImmunology 10:1.
Read now
Read now
Articles from other publishers (17)
Guido Kroemer, Timothy A. Chan, Alexander M. M. Eggermont & Lorenzo Galluzzi. (2023) Immunosurveillance in clinical cancer management. CA: A Cancer Journal for Clinicians 74:2, pages 187-202.
Crossref
Crossref
Ilona Tornyi, Peter Árkosy, Ildikó Horváth & Andrea Furka. (2023) A new perspective on the proper timing of radiotherapy during CDK4/6 inhibitor therapy in patients with “bone-only” metastatic breast cancer. Pathology and Oncology Research 29.
Crossref
Crossref
Vanessa Klapp, Aitziber Buqué, Norma Bloy, Ai Sato, Takahiro Yamazaki, Xi Kathy Zhou, Silvia C. Formenti, Lorenzo Galluzzi & Giulia Petroni. (2023) Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors. Journal of Translational Medicine 21:1.
Crossref
Crossref
Titiek Hidayati, Indrayanti Indrayanti, Endang Darmawan & Akrom Akrom. (2023) Herbal Honey Preparations of Curcuma Xanthorriza and Black Cumin Protect against Carcinogenesis through Antioxidant and Immunomodulatory Activities in Sprague Dawley (SD) Rats Induced with Dimethylbenz(a)anthracene. Nutrients 15:2, pages 371.
Crossref
Crossref
Emma Guilbaud, Sheila Spada, Norma Bloy, Claudia Galassi, Ai Sato, Carlos Jiménez-Cortegana, Artur Aretz, Aitziber Buqué, Takahiro Yamazaki, Sandra Demaria & Lorenzo Galluzzi. 2023. Radiation Oncology and Radiotherapy. Radiation Oncology and Radiotherapy
93
111
.
Céline Mirjolet, Jérémy Baude & Lorenzo Galluzzi. 2023. Ionizing Radiation and the Immune Response - Part B. Ionizing Radiation and the Immune Response - Part B
xiii
xxiv
.
Ai Sato, Jeffrey Kraynak, Ariel E. Marciscano & Lorenzo Galluzzi. 2023. Radiation Oncology and Radiotherapy Part C. Radiation Oncology and Radiotherapy Part C
xv
xxv
.
Ai Sato, Jeffrey Kraynak, Ariel E. Marciscano & Lorenzo Galluzzi. 2023. Radiation Oncology and Radiotherapy. Radiation Oncology and Radiotherapy
xv
xxv
.
Jitka Fucikova, Michal Hensler, Lenka Kasikova, Tereza Lanickova, Josef Pasulka, Jana Rakova, Jana Drozenova, Tessa Fredriksen, Marek Hraska, Tereza Hrnciarova, Klara Sochorova, Daniela Rozkova, Ludek Sojka, Pavel Dundr, Jan Laco, Tomas Brtnicky, Ivan Praznovec, Michael J. Halaska, Lukas Rob, Ales Ryska, An Coosemans, Ignace Vergote, David Cibula, Jirina Bartunkova, Jérôme Galon, Lorenzo Galluzzi & Radek Spisek. (2022) An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors. Clinical Cancer Research 28:14, pages 3053-3065.
Crossref
Crossref
Giulia Petroni, Aitziber Buqué, Lisa M. Coussens & Lorenzo Galluzzi. (2022) Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. Nature Reviews Drug Discovery 21:6, pages 440-462.
Crossref
Crossref
Carlos Jiménez-Cortegana, Claudia Galassi, Vanessa Klapp, Dmitry I. Gabrilovich & Lorenzo Galluzzi. (2022) Myeloid-Derived Suppressor Cells and Radiotherapy. Cancer Immunology Research 10:5, pages 545-557.
Crossref
Crossref
Jitka Fucikova, Lenka Palova-Jelinkova, Vanessa Klapp, Peter Holicek, Tereza Lanickova, Lenka Kasikova, Jana Drozenova, David Cibula, Beatriz Álvarez-Abril, Elena García-Martínez, Radek Spisek & Lorenzo Galluzzi. (2022) Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents. Trends in Cancer 8:5, pages 426-444.
Crossref
Crossref
Julie Constanzo, Lorenzo Galluzzi & Jean-Pierre Pouget. (2022) Immunostimulatory effects of radioimmunotherapy. Journal for ImmunoTherapy of Cancer 10:2, pages e004403.
Crossref
Crossref
Giulia Petroni, Lewis C. Cantley, Laura Santambrogio, Silvia C. Formenti & Lorenzo Galluzzi. (2021) Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nature Reviews Clinical Oncology 19:2, pages 114-131.
Crossref
Crossref
Carlos Jiménez-Cortegana, Vanessa Klapp, Norma Bloy, Claudia Galassi, Ai Sato, Takahiro Yamazaki, Aitziber Buqué, Lorenzo Galluzzi & Giulia Petroni. 2022. Radiation Oncology and Radiotherapy Part A. Radiation Oncology and Radiotherapy Part A
1
16
.
Ai Sato, Jeffrey Kraynak, Ariel E. Marciscano & Lorenzo Galluzzi. 2022. Radiation Oncology and Radiotherapy Part A. Radiation Oncology and Radiotherapy Part A
xiii
xxiii
.
Jitka Fucikova, An Coosemans, Sandra Orsulic, David Cibula, Ignace Vergote, Lorenzo Galluzzi & Radek Spisek. (2021) Immunological configuration of ovarian carcinoma: features and impact on disease outcome. Journal for ImmunoTherapy of Cancer 9:10, pages e002873.
Crossref
Crossref